|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Capitalization1 |
354 885 | 307 619 | 285 686 | 222 685 | 222 685 | - |
| Entreprise Value (EV)1 |
911 374 | 855 756 | 995 938 | 909 228 | 861 841 | 830 903 |
| P/E ratio |
12,0x | 7,26x | 15,1x | 6,81x | 5,94x | 5,26x |
| Yield |
- | - | 3,31% | 6,64% | 7,38% | 8,09% |
| Capitalization / Revenue |
0,91x | 0,56x | 0,55x | 0,34x | 0,30x | 0,28x |
| EV / Revenue |
2,34x | 1,57x | 1,91x | 1,38x | 1,17x | 1,03x |
| EV / EBITDA |
8,59x | 5,28x | 9,66x | 8,19x | 6,74x | 6,38x |
| Price to Book |
2,50x | 1,98x | 1,78x | 1,03x | 0,91x | 0,89x |
| Nbr of stocks (in thousands) |
13 168 260 | 13 118 064 | 13 226 188 | 13 239 285 | 13 239 285 | - |
| Reference price (HKD) |
27,0 | 23,5 | 21,6 | 15,7 | 15,7 | 15,7 |
| Last update |
03/26/2018 | 03/26/2019 | 03/31/2020 | 01/13/2021 | 01/13/2021 | 01/13/2021 |
|
1 HKD in Million Estimates
|
|
| Income Statement Evolution | |
|
|
|
| Annual Income Statement Data |
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Net sales1 |
389 030 | 544 938 | 522 699 | 657 017 | 739 253 | 804 798 |
| EBITDA1 |
106 069 | 162 081 | 103 113 | 110 953 | 127 934 | 130 169 |
| Operating profit (EBIT)1 |
103 575 | 159 027 | 98 330 | 108 292 | 121 242 | 126 513 |
| Operating Margin |
26,6% | 29,2% | 18,8% | 16,5% | 16,4% | 15,7% |
| Pre-Tax Profit (EBT)1 |
96 904 | 148 176 | 81 183 | 100 747 | 114 234 | 123 076 |
| Net income1 |
30 485 | 43 705 | 18 913 | 29 890 | 34 117 | 37 861 |
| Net margin |
7,84% | 8,02% | 3,62% | 4,55% | 4,62% | 4,70% |
| EPS2 |
2,25 | 3,23 | 1,43 | 2,30 | 2,64 | 2,98 |
| Dividend per Share2 |
- | - | 0,71 | 1,04 | 1,16 | 1,27 |
| Last update |
03/26/2018 | 03/26/2019 | 03/31/2020 | 01/20/2021 | 01/20/2021 | 01/20/2021 |
|
1 HKD in Million 2 HKD Estimates
|
|
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Net Debt1 |
556 489 | 548 137 | 710 253 | 686 544 | 639 157 | 608 218 |
| Net Cash position1 |
- | - | - | - | - | - |
| Leverage (Debt / EBITDA) |
5,25x | 3,38x | 6,89x | 6,19x | 5,00x | 4,67x |
| Free Cash Flow1 |
-204 901 | 52 744 | -90 335 | 40 095 | 124 452 | 106 221 |
| ROE (Net Profit / Equities) |
30,7% | 30,2% | 12,4% | 17,8% | 18,5% | 17,0% |
| Shareholders' equity1 |
99 447 | 144 808 | 152 518 | 167 535 | 184 101 | 222 508 |
| ROA (Net Profit / Asset) |
1,57% | 2,05% | 0,85% | 1,83% | 1,99% | 2,53% |
| Assets1 |
1 946 664 | 2 128 436 | 2 236 432 | 1 633 235 | 1 711 213 | 1 494 490 |
| Book Value Per Share2 |
10,8 | 11,9 | 12,1 | 15,2 | 17,3 | 17,5 |
| Cash Flow per Share2 |
-13,8 | 4,69 | -5,56 | 8,67 | 13,2 | 13,6 |
| Capex1 |
17 807 | 11 206 | 12 959 | 7 095 | 7 354 | 7 409 |
| Capex / Sales |
4,58% | 2,06% | 2,48% | 1,08% | 0,99% | 0,92% |
| Last update |
03/26/2018 | 03/26/2019 | 03/31/2020 | 01/13/2021 | 01/13/2021 | 01/13/2021 |
|
1 HKD in Million 2 HKD Estimates
|
|
|
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
Take Five: A shot in the arm |
Capitalization (HKD) 222 684 772 018 Capitalization (USD) 28 724 549 498 Net sales (HKD) 522 699 348 420 Net sales (USD) 67 433 442 940 Number of employees 131 615 Sales / Employee (HKD) 3 971 427 Sales / Employee (USD) 512 354 Free-Float capitalization (HKD) 31 989 153 415 Free-Float capitalization (USD) 4 126 344 214 Avg. Exchange 20 sessions (HKD) 316 074 931 Avg. Exchange 20 sessions (USD) 40 776 827 Average Daily Capital Traded 0,14%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Evolution Valeur d'Entreprise / EBITDA
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
